Immunotherapeutic approaches to curtail COVID-19

H Owji, M Negahdaripour, N Hajighahramani - International …, 2020 - Elsevier
COVID-19, the disease induced by the recently emerged severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), has imposed an unpredictable burden on the world. Drug …

Immunotherapies and immunomodulatory approaches in clinical trials-a mini review

M Iqbal Yatoo, Z Hamid, I Rather… - Human vaccines & …, 2021 - Taylor & Francis
ABSTRACT The coronavirus disease (COVID-19) pandemic caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has created havoc worldwide. Due to the …

The immune system as a target for therapy of SARS-CoV-2: a systematic review of the current immunotherapies for COVID-19

AH Mansourabadi, M Sadeghalvad… - Life sciences, 2020 - Elsevier
Aims The immune response is essential for the control and resolution of viral infections.
Following the outbreak of novel coronavirus disease (COVID-19), several immunotherapies …

[HTML][HTML] A comprehensive insight into current control of COVID-19: Immunogenicity, vaccination, and treatment.

Y Mohamed, YA El-Maradny, AK Saleh… - Biomedicine & …, 2022 - Elsevier
The healthy immune system eliminates pathogens and maintains tissue homeostasis
through extraordinarily complex networks with feedback systems while avoiding potentially …

[HTML][HTML] The three pillars of COVID-19 convalescent plasma therapy

M Franchini, GM Liumbruno, G Piacentini, C Glingani… - Life, 2021 - mdpi.com
The new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has
spread rapidly around the world in the last year causing the coronavirus disease 2019 …

Coronavirus disease 2019 (COVID-19): Immunological approaches and emerging pharmacologic treatments

P Goodarzi, F Mahdavi, R Mirzaei, H Hasanvand… - International …, 2020 - Elsevier
The SARS-CoV-2 virus is an etiological agent of pandemic COVID-19, which spreads
rapidly worldwide. No proven effective therapies currently exist for this virus, and efforts to …

Antibody-based immunotherapeutics and use of convalescent plasma to counter COVID-19: advances and prospects

K Sharun, R Tiwari, M Iqbal Yatoo… - Expert Opinion on …, 2020 - Taylor & Francis
ABSTRACT Introduction Coronavirus disease 2019 (COVID-19) has spread to several
countries globally. Currently, there is no specific drug or vaccine available for managing …

Recent advances in vaccine and immunotherapy for COVID-19

AA Rabaan, SH Al-Ahmed, R Sah… - Human vaccines & …, 2020 - Taylor & Francis
The COVID-19 pandemic caused by SARS-CoV-2 has resulted in millions of cases and
hundreds of thousands of deaths. Beyond there being no available antiviral therapy …

The possible of immunotherapy for COVID-19: A systematic review

A AminJafari, S Ghasemi - International immunopharmacology, 2020 - Elsevier
Abstract The novel coronavirus (2019-nCoV) is an emerging pathogen that was first
described in late December 2019 and causes a severe respiratory infection in humans …

[HTML][HTML] Immunotherapy for SARS-CoV-2: potential opportunities

M Pashaei, N Rezaei - Expert opinion on biological therapy, 2020 - Taylor & Francis
Coronavirus Disease 2019 (COVID-19), caused by a novel coronavirus, called Severe Acute
Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), emerged at the end of 2019 in Wuhan …